Noncompliance and missing data often occur in randomized trials, which complicate the inference of causal effects. When both noncompliance and missing data are present, previous papers proposed moment and maximum likelihood estimators for binary and normally distributed continuous outcomes under the latent ignorable missing data mechanism. However, the latent ignorable missing data mechanism may be violated in practice, because the missing data mechanism may depend directly on the missing outcome itself. Under noncompliance and an outcome-dependent nonignorable missing data mechanism, previous studies showed the identifiability of complier average causal effect for discrete outcomes. In this article, we study the semiparametric identifiability and estimation of complier average causal effect in randomized clinical trials with both all-or-none noncompliance and outcome-dependent nonignorable missing continuous outcomes, and propose a two-step maximum likelihood estimator in order to eliminate the infinite dimensional nuisance parameter. Our method does not need to specify a parametric form for the missing data mechanism. We also evaluate the finite sample property of our method via extensive simulation studies and sensitivity analysis, with an application to a double-blinded psychiatric clinical trial. 
INTRODUCTION
Randomization is an effective way to study the average causal effects (ACEs) of new drugs or training programs. However, randomized trials are often plagued with noncompliance and missing data, which may make statistical inference difficult and biased. The noncompliance problem happens when some subjects fail to comply with their assigned treatments, and the missing data problem happens when investigators fail to collect information for some subjects. Ignoring noncompliance and missing data problems may lead to biased estimators of the ACEs.
The noncompliance problem has attracted a lot of attention in the literature. Efron and Feldman [1991] studied the noncompliance problem before the principal stratification framework [Frangakis and Rubin 2002] was proposed. In the presence of noncompliance, Balke and Pearl [1997] proposed large sample bounds of the ACEs for binary outcomes using the linear programming method. Angrist et al. [1996] discussed the identifiability of the causal effect using the instrumental variable method. Imbens and Rubin [1997] proposed a Bayesian method to estimate the complier average causal effect (CACE). When some outcomes are missing, the identifiability and estimation of CACE are more complicated, and different types of missing data mechanisms have sizable impacts on the identifiability and estimation of CACE. Frangakis and Rubin [1999] established the identifiability and proposed a moment estimator of CACE under the latent ignorable (LI) missing data mechanism. Under the LI missing data mechanism, Zhou and Li [2006] and O'Malley and Normand [2005] proposed ExpectationMaximization (EM) algorithms [Dempster et al. 1977 ] to find the maximum likelihood estimators (MLEs) of CACE for binary and normally distributed outcomes, respectively. Barnard et al. [2003] proposed a Bayesian approach to estimate CACE with bivariate outcomes and covariate adjustment. Taylor and Zhou [2011] proposed a multiple imputation method to estimate CACE for clustered encouragement design studies.
However, the LI assumption may be implausible in some clinical studies when the missing data mechanism may depend on the missing outcome. Chen et al. [2009] and Imai [2009] discussed the identifiability of CACE for discrete outcomes under the outcome-dependent nonignorable (ODN) missing data mechanism. To the best of our knowledge, there are no published papers in the literature studying the identifiability of CACE for continuous outcomes under the ODN assumption. In this article, we show that CACE is semiparametrically identifiable under some regular conditions, and propose estimation methods for CACE with continuous outcomes under the ODN assumption. For our semiparametric method, we need only to assume that the distribution of the outcomes belongs to the exponential family without specifying a parametric form for the missing data mechanism.
This article proceeds as follows. In Section 2, we discuss the notation and assumptions used in this article and define the parameter of interest. In Section 3, we show the semiparametric identifiability and propose a two-step maximum likelihood estimator (TSMLE). In Section 4, we use several simulation studies to illustrate the finite sample properties of our proposed estimators and consider sensitivity analysis to assess the robustness of our estimation strategy. In Section 5, we analyze a double-blinded randomized clinical trial using the methods proposed in this article. We conclude with a discussion in Section 6 and provide all proofs in the Appendices.
NOTATION AND ASSUMPTIONS
We consider a randomized trial with a continuous outcome. For the i-th subject, let Z i denote the randomized treatment assignment (1 for treatment and 0 for control). Let D i denote the treatment received (1 for treatment and 0 for control Assumption 1 (Stable unit treatment value assumption, SUTVA). There is no interference between units, which means that the potential outcomes of one individual do not depend on the treatment status of other individuals [Rubin 1980 ], and there is only one version of potential outcome of a certain treatment [Rubin 1986 ].
Except in the dependent case for infectious diseases [Hudgens and Halloran 2008] , the SUTVA assumption is reasonable in many cases. Under the SUTVA assumption, we define D i (z), Y i (z), and R i (z) as the potential treatment received, the potential outcome measured, and the potential missing data indicator for subject i if the subject were assigned to treatment z. These variables are potential outcomes because only one of the pairs
are the observed treatment received, the observed outcome, and the observed missing data indicator, respectively.
Under the principal stratification framework [Angrist et al. 1996; Frangakis and Rubin 2002] , we let U i be the compliance status of subject i, defined as follows:
where a, c, d, and n represent "always-taker," "complier," "defier," and "never-taker," respectively. Here, U i is an unobserved variable, because we can observe only D i (1) or D i (0) for subject i, but not both. The CACE of Z to Y is the parameter of interest, defined as
CACE is a subgroup causal effect for the compliers, with incompletely observed compliance status. Next, we give some sufficient conditions about the latent variables to make CACE(Z → Y ) identifiable, in the presence of noncompliance and nonignorable missing outcomes.
Assumption 2 (Randomization).
The treatment assignment Z is completely randomized.
Randomization means that
The monotonicity of D i (z) implies that there are no defiers. Define ω u = P(U = u) for u = a, c, d, n, and the monotonicity assumption implies ω d = 0. Assumption 3 is plausible when the treatment assignment has a nonnegative effect on the treatment received for each subject, and it holds directly when the treatment is not available to subjects in the control arm, meaning that D i (0) = 0 for all subjects. The monotonicity assumption implies a positive ACE of Z on D. However, under general circumstances, Assumption 3 is not fully testable, since only one of D i (1) and D i (0) can be observed. 
Assumption 5 (Compound exclusion restrictions).
For never-takers and alwaystakers, we assume that P{Y (1), R(1)|U = n} = P{Y (0), R(0)|U = n}, and
The traditional exclusion restriction assumes that P{Y (1)|U = u} = P{Y (0)|U = u} for u = a and n. Frangakis and Rubin [1999] extended it to the compound exclusion restrictions, and imposed a similar assumption on the joint vector of the outcome and the missing data indicator. Assumption 5 is reasonable in a double-blinded clinical trial, because the patients do not know the treatment assigned to them; thus, Z has no "direct effect" on the outcome and the missing data indicator. However, when the missing data indicator depends on the treatment assigned, the compound exclusion restrictions may be violated. When Z is randomized, Assumption 5 is equivalent to
Assumption 6 (Outcome-dependent nonignorable missing data). For all y; z = 0, 1; d = 0, 1; and u ∈ {a, c, n}, we assume that
When Z is randomized, Equation (1) becomes
, and Equation (2) becomes
. Therefore, Assumption 2 and Assumption 6 imply that ρ(y)
In previous articles [Frangakis and Rubin 1999; O'Malley and Normand 2005; Zhou and Li 2006] , the LI assumption is used for modeling missing data, which means that the potential outcomes and associated potential nonresponse indicators are independent within each principal stratum, that is,
Under the ODN missing data mechanism, the missing data indicator depends on the possibly missing outcome Y , which may be more reasonable than the LI missing data assumption in some applications. For example, some patients may have higher probabilities of leaving a trial if their health outcomes are not good, and they may be more likely to stay in a trial otherwise. We illustrate the LI and ODN missing data mechanisms using the graphical models in Figure 1 . The randomization, compound exclusion restriction, and LI assumption implies that P(R = 1| Z = 1, U = n) = P(R = 1|Z = 0, U = n) = P(R = 1|U = n) for never-takers, and Therefore, the missing data mechanism depends only on (D, U ) under Assumptions 2, 5, and LI, which implies that the arrow from Z to R is absent in Figure 1 (a).
SEMIPARAMETRIC IDENTIFIABILITY AND ESTIMATION
In this section, we first discuss the difficulty of nonparametric identifiability without assuming a parametric form for both the outcome distribution and the missing data mechanism. If both the distribution of the outcome Y and the missing data mechanism ρ(y) are not specified, the model is essentially not identifiable without further assumptions. We then propose a semiparametric method, specifying only the distribution of Y without assuming any parametric form for the missing data mechanism. We show the identifiability and propose a TSMLE of CACE(Z → Y ) under the assumption that the distribution of the outcome variable Y belongs to the exponential family.
Semiparametric Identifiability
Under SUTVA, randomization and monotonicity assumptions, we have ξ = P(Z = 1),
, and ω c = 1 − ω a − ω n . These parameters can be identified directly from the observed data. Next, we focus on the identification of the parameters of Y .
Assumption 7. The conditional density of the outcome variable Y belongs to the following exponential family:
where c(·), h(·), p k (·), and T k (·) are known functions, and θ = {θ zu : z = 0, 1; u = c, a, n} are unknown parameters.
The parametric assumption of the outcome is untestable in general, since the missing data mechanism depends arbitrarily on the outcome. But for binary outcome, Small and Cheng [2009] proposed a goodness-of-fit test for the model under the ODN missing data mechanism. When the randomization assumption holds, the CACE is the difference between the expectations of the conditional density of Y , that is,
Hence, if the parameters of f zu (y) are identified, the CACE is also identified. The exponential family defined by Assumption 7 includes many common distributions, such as normal distributions N(μ zu , σ 2 ), exponential distributions Exp(λ zu ) with mean parameter 1/λ zu , Gamma distributions Gamma(α zu , λ) with shape parameter α zu and rate parameter λ, and the log-normal distributions Lognormal(μ zu , σ 2 ), where CACEs are specified as CACE nor = μ 1c −μ 0c , CACE exp = 1/λ 1c −1/λ 0c , CACE gam = α 1c /λ−α 0c /λ, and CACE log = exp{μ 1c + σ 2 /2} − exp{μ 0c + σ 2 /2}, respectively. Next, Theorem 3.1 will show the identifiability of the parameters of θ . The proof of Theorem 3.1 is provided in Appendix A. Assumption 5 implies that θ 1n = θ 0n and θ 1a = θ 0a , which can be simplified as θ n and θ a , respectively. THEOREM 3.1. Under Assumptions 1 to 7, the vector η
If there exists a one-to-one mapping from the parameter set θ to the vector η, then θ is identifiable and so is CACE.
The one-to-one mapping condition seems complicated, but it is reasonable and holds for many widely used distributions, such as homoskedastic normal distributions, exponential distributions, and so forth. We will verify the one-to-one mapping condition for normal and exponential distributions in Appendix C and Appendix D. Other distributions such as heteroskedastic normal distributions, Gamma distributions, and lognormal distributions can be verified similarly. However, counterexamples do exist; we provide one in Appendix A.
TSMLE of CACE
Because we do not specify a parametric form for the missing data mechanism ρ(y), the joint distribution of (Z, U, D, Y, R) is not specified completely. Thus, the MLEs of parameters are hard to obtain, since the likelihood depends on the infinite dimensional parameter ρ(y) as shown in Appendix B. In this subsection, we propose a two-step likelihood method to estimate parameters, which can be viewed as an example of the Two-Step Maximum Likelihood studied by Murphy and Topel [2002] .
In the first step, a consistent estimator for α = (ξ, ω a , ω n ) can be obtained by MLE using the data {(Z i , D i ) : i = 1, . . . , N}. Let N denote the sample size, N 1 = #{i : Z i = 1}, N 0 = #{i : Z i = 0}, and n zd = #{i : Z i = z, D i = d} for z = 0, 1 and d = 0, 1. Then the log likelihood function for α is l 1 (α) = N 1 log ξ + N 0 log(1 − ξ ) + n 11 log(1 − ω n ) + n 10 log(ω n ) + n 01 log(ω a ) + n 00 log(1 − ω a ).
(4) The MLE for α isα = (ξ,ω n ,ω a ) = (N 1 /N, n 10 /N 1 , n 01 /N 0 ), equivalent to the moment estimator.
In the second step, we propose a conditional likelihood method to estimate the parameter set θ , which is based on the conditional probability of (Z, D) given Y and R = 1. Here, the proposed conditional likelihood function does not depend on the nuisance parameter ρ(y), based on the fact that the following Equations (5) to (7) do not depend on ρ(y):
log
It is obvious that
The left-hand sides of Equations (5) to (7) consist of P(Z = z, D = d|Y = y, R = 1) and ξ , with the latter identified from the first step. The right-hand sides of Equations (5) to (7) consist of the parameters of interest. Therefore, we can estimate θ through a likelihood method. Note that the right-hand sides do not depend on ρ(y), thus we do not need to specify the form of ρ(y). Let p zd (θ, α; y) denote P(Z = z, D = d|Y = y, R = 1). Since (Z, D) given (Y = y, R = 1) follows a multinomial distribution with four categories, the conditional log-likelihood function of (Z, D) can be written as
From the proof of Theorem 3.1, the parameter θ can be identified from the second likelihood function in (9) after identifying α from the first likelihood function in (4). Therefore, by maximizing l 2 (θ,α) over θ , we obtain the maximizerθ. In practice, we can use the bootstrap method to approximate the sampling variance of the estimator of CACE.
SIMULATION STUDIES AND SENSITIVITY ANALYSIS
We report simulation studies and sensitivity analyses in order to evaluate the finite sample properties of the estimating methods proposed in this article. In Tables II through IV, the columns with the labels "bias," "Std.dev.," "95% CP," and "95% CI" represent the average bias, standard deviation, 95% coverage proportion and average 95% confidence interval, respectively. First, we generate the outcomes under the ODN missing data mechanism from homoskedastic normal distributions (denoted as "homo normal"), exponential distributions, Gamma distributions and log-normal distributions, respectively. We set the number of simulations to be 10000, and choose the sample sizes as 500, 1000, 2000, and 4000, respectively. We show the joint distributions of (Z, U, D, Y, R) in Table I , and report the results in Table II . The results have small biases and standard deviations, which decrease as the sample sizes become larger. All of the confidence intervals of CACE have empirical coverage proportions very close to their nominal values.
Second, we report the results of comparison of our methods with the MLE proposed by O'Malley and Normand [2005] ("LI" in Tables III) under five different cases, which violate the homoskedastic normal outcomes or the ODN assumption. We repeat our simulation 10000 times with sample sizes of 4000 in each case. The results of five cases are shown in Table III , named "Heter," "Unif," "T," "DY," and "DYU," respectively. The first case, the "Heter" case, violates the homoskedastic normal outcomes. The next two cases, "Unif " and "T," violate the exponential family assumption. The last two cases, "DY" and "DYU," violate the ODN assumption. In the "Heter" case, we generate data from heteroskedastic normal outcomes. The data-generating process is the same as "homo normal" except that Y (1)|U = c ∼ N(5, 0.25), Y (z)|U = a ∼ N(6, 0.30) for z = 0, 1. In the "Unif " case, the data is generated the same as "homo normal" except that the outcomes follow uniform distribution with 3, 9] , and Y (z)|U = n ∼ U [1, 5] , respectively. The data-generating process in the "T" case is the same as "homo normal" except that the outcomes follow t distributions with the same means as "homo normal" and degrees of freedom 4. In the "DY" case, we generate data under the missing data mechanism depending on both D and Y , and choose
1 with other conditional distributions the same as "homo normal." In the "DYU" case, we generate data with the missing data mechanism depending on D, Y , and U , and choose
, with other conditional distributions the same as "homo normal" and U = 1, 2, 3 corresponding to U = c, n, a. From Table III , we can see that the point estimator of our method is generally robust to four kinds of violations of the assumptions. However, the results are worse for the "Unif " case, which has a large bias, low 95% coverage proportion, and whose 95% confidence interval does not cover the true value.
Finally, we compare our methods with the MLE proposed by O'Malley and Normand (2005) under the LI missing data mechanism ("LI" in Table IV ). We repeat our simulation 10000 times with sample sizes of 4000 in each case. The data-generating processes are the same as "homo normal," but the missing data mechanisms are LI. Denote γ du = P(R = 1|D = d, U = u), and choose (γ 1c , γ 0c , γ 0n , γ 1a ) = (0.8, 0.75, 0.7, 0.9), (0.9, 0.7, 0.8, 0.7), (0.7, 0.6, 0.6, 0.8) and (0.6, 0.7, 0.9, 0.7) for "LI1" to "LI4," respectively, as shown in Rows 1 through 4 and 5 through 8 of Table IV . Since the missing data mechanisms are LI, the "LI" method exhibits very small biases. Although the assumptions required by the "ODN" methods do not hold, the biases are not very large except for the missing mechanism LI4. The last case, LI4, has the largest variability among the γ zu 's and thus the largest bias for estimating the CACE, since the missing data mechanism has the "strongest" dependence on D and U , but not Y . Next, we generate data under the ODN assumption, and compare the methods under both ODN and LI assumptions. Let ρ(y; δ) = I(y ≤ 2) × (0.9 − δ) + I(y ≥ 7) × (0.9 − 2δ) + I(2 < y < 7) × 0.9, where 0 < δ < 0.9. As δ increases, the relationship between Y and R becomes stronger. The data are generated from the same joint distribution as "homo normal" except for different ρ(y; δ). The results are shown in Figure 2 . The method under the ODN missing data mechanism has small bias and promising coverage property irrespective of δ, but the method under the LI missing data mechanism has a larger bias and poorer coverage property with larger δ.
APPLICATION
We use the new methods proposed in this article to reanalyze a psychiatric clinical trial. It is a double-blinded, randomized study comparing the relative effect of clozapine and haloperidol in adults with refractory schizophrenia at 15 Veterans Affairs medical centers. Clozapine is found to be more efficacious than standard drugs in patients with refractory schizophrenia. Yet it is associated with potentially fatal agranulocytosis. One objective for conducting this trial is to evaluate the clinical effect of two antipsychotic medications. The dataset has been analyzed in Rosenheck et al. [1997] , Levy et al. [2004], and Normand [2005] . Some summary statistics of the data are presented in Table V . More details about the trial can be found in Rosenheck et al. [1997] and Normand [2005] . In the treatment arm, 203 patients are randomized to clozapine; in the control arm, 218 patients are randomized to haloperidol. The outcome of interest is the positive and negative syndrome score (PANSS), with higher values indicating more severe symptoms. The baseline PANSS is nearly balanced in both groups. Missing outcome patterns are obviously different in the clozapine group (about 40/203 ≈ 0.20) than in the haloperidol group (about 59/218 ≈ 0.27). Hence, it is possible that outcomes are not missing at random. The primary reasons for dropout in the clozapine group are side effects or nondrug-related reasons. The reasons for discontinuing haloperidol are lack of efficacy or worsening of symptoms. Therefore, the missing mechanism may possibly depend on the missing outcome; we think that the ODN assumption may be more reasonable in this case. The estimates of CACE by different methods are shown in Table VI . In Table VI , the "homo" and "hetero" in parentheses after "ODN" correspond to the homoskedastic and heteroskedastic model assumptions, respectively; "LI" corresponds to the MLE proposed in O'Malley and Normand [2005] . The columns of Table VI correspond to the methods, point estimates, standard errors, 95% and 90% confidence intervals, respectively. The bootstrap method is used to compute standard errors and confidence intervals for all methods. From Table VI, we can see that, under the homoskedastic assumption, subjects in the clozapine group had 5.00 lower symptom levels than those in the haloperidol group, and under the heteroskedastic assumption, it was 5.54. Both methods produce a similar conclusion: that clozapine is somewhat more effective than haloperidol for patients with refractory schizophrenia. Both of the semiparametric methods give insignificant results since both 95% confidence intervals include zero. Our results are similar to O'Malley and Normand [2005] , who also produced an insignificant result. However, the results of the 90% confidence intervals are somewhat different: the result under the ODN mechanism with the heteroskedastic assumption is significant, but the results from the other two models are not.
Assuming different missing data mechanisms, such as LI and ODN, and under other different assumptions on the outcome variable, we can find different point estimates and confidence intervals for CACE using the data from the psychiatric clinical trial. When we have prior knowledge that the missing mechanism depends only on the treatment received and the compliance status, the method under the LI missing mechanism will provide a more credible conclusion. However, when we have prior knowledge that the missing mechanism depends directly on the outcome, we recommend our methods under the ODN missing data mechanism. The newly proposed methods can be used as alternatives for the predominate methods assuming the LI missing mechanism in sensitivity analysis.
DISCUSSION
Randomization is a powerful tool to measure the relative causal effect of treatment versus control. Some subjects in randomized trials, however, may fail to comply with the assigned treatments or drop out before the final outcomes are measured. Noncompliance and missing data problems make statistical causal inference difficult, because the causal effects are not identifiable without additional assumptions. Under different assumptions about the missing data mechanisms of the outcomes, the identifiability and estimation methods may be fundamentally different. Most previous studies [Frangakis and Rubin 1999; Barnard et al. 2003; O'Malley and Normand 2005; Zhou and Li 2006] rely on the LI assumption in order to identify CACE, but the LI assumption may not be reasonable when the missing data mechanism may depend on the outcome. Under the ODN missing data mechanism, Chen et al. [2009] and Imai [2009] showed the identifiability and proposed the moment estimator and the MLE of CACE for discrete outcomes. However, there are no results for continuous outcomes under both noncompliance and ODN missing data mechanisms. As a generalization of Chen et al. [2009] and Imai [2009] , we study the semiparametric identifiability, and propose estimation methods for CACE with continuous outcomes under the ODN missing data mechanism.
The ODN assumption allows the missing data mechanism to depend on the outcome. This missing data mechanism may be plausible when the patients leave the trial because of the lack of efficacy of the treatment on the outcome. For example, Small and Cheng [2009] gave a real-life data application [Mealli et al. 2004] in which the outcomedependent missing data mechanism fits the data very well. However, the missing data processes in practical problems may be more complicated, and they may depend on other variables such as Z, U , and D. For example, a missing mechanism depending on both the compliance status and the outcome may be reasonable in some real studies. Small and Cheng [2009] proposed a saturated model for P(R = 1|Z, U, Y ), and the models under LI and ODN are special cases of their model. However, their model is generally not identifiable without restrictions on the parameters. It is worthwhile to study the identifiability of CACE under all possible restrictions of P(R = 1|Z, U, Y ) and perform sensitivity analysis for models' lack of identifiability. We consider only cross-sectional data in this article; generalizing our methods to longitudinal data is a future research topic. Therefore, we can identify CACE = μ 1c − μ 0c .
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